{"id":65145,"date":"2024-10-16T14:17:31","date_gmt":"2024-10-16T14:17:31","guid":{"rendered":"https:\/\/hub.onequity.com\/?p=4288"},"modified":"2024-10-16T14:17:31","modified_gmt":"2024-10-16T14:17:31","slug":"todays-stocks-to-watch-asml-morgan-stanley-and-novocure","status":"publish","type":"post","link":"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/","title":{"rendered":"Today&#8217;s Stocks to Watch: ASML, Morgan Stanley, and Novocure"},"content":{"rendered":"\n<p><em>Key points:<\/em><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Luxury stocks, including LVMH, suffer declines in challenging global markets<\/li>\n\n\n\n<li>Morgan Stanley&#8217;s earnings beat estimates, outperforming among stocks<\/li>\n\n\n\n<li>Novocure wins FDA approval, boosting its shares considerably<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>LVMH Faces Challenges in Global Markets<\/strong><\/h2>\n\n\n\n<p>LVMH (MC): LVMH, the owner of Louis Vuitton, reported disappointing results and stated it is facing challenges in most markets. Shares of the French company, along with other European luxury stocks, declined sharply.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Morgan Stanley Beats Expectations with Earnings<\/strong><\/h2>\n\n\n\n<p>Morgan Stanley (MS): The bank reported quarterly results that exceeded expectations, with significant growth in investment banking revenues. Morgan Stanley shares rose nearly 2.5% in pre-market trading, boosting investor confidence in its performance.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Equifax, PPG Industries, and Alcoa Results<\/strong><\/h2>\n\n\n\n<p>Equifax (EFX), PPG Industries (PPG), and Alcoa (AA): These companies are expected to release their earnings results after U.S. markets close. Investors will closely monitor their performance, which could shape overall sector sentiment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>ASML and the Fall of Semiconductor Sector Stocks<\/strong><\/h2>\n\n\n\n<p>ASML (ASML): The semiconductor equipment maker continues to decline, with its Amsterdam-listed shares down around 4%. This drop adds to the unfavorable performance of other global semiconductor stocks, including TSMC and Tokyo Electron.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Intel Faces Security Concerns in China<\/strong><\/h2>\n\n\n\n<p>Intel (INTC): The Cybersecurity Association of China has stated that Intel products sold in China should undergo a cybersecurity review, citing concerns that the U.S. manufacturer poses a threat to national security. This has led to a 1.5% drop in Intel&#8217;s stock in pre-market trading.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Novocure Celebrates Approval of Its Lung Cancer Treatment<\/strong><\/h2>\n\n\n\n<p>Novocure (NVCR): Novocure shares surged by about a third in after-hours trading after the U.S. Food and Drug Administration approved its Optune Lua portable lung cancer treatment. This approval marks a major milestone for the company and strengthens its position in the market.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>J.B. Hunt Surprises with Better-Than-Expected Revenues<\/strong><\/h2>\n\n\n\n<p>J.B. Hunt (JBHT): The transportation and logistics company reported a drop in quarterly revenue, but the decline was less than analysts had expected. As a result, the stock rose nearly 7% in pre-market trading, driven by a better-than-expected performance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key points: LVMH Faces Challenges in Global Markets LVMH (MC): LVMH, the owner of Louis Vuitton, reported disappointing results and [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[633],"tags":[695,646],"class_list":["post-65145","post","type-post","status-publish","format-standard","hentry","category-stocks","tag-stock-market","tag-stocks-tag"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Today&#039;s Stocks to Watch: ASML, Morgan Stanley, and Novocure - OnEquity<\/title>\n<meta name=\"description\" content=\"Today&#039;s stocks to watch: ASML slides, Morgan Stanley beats earnings, and Novocure rises after FDA approval of its lung cancer treatment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Today&#039;s Stocks to Watch: ASML, Morgan Stanley, and Novocure - OnEquity\" \/>\n<meta property=\"og:description\" content=\"Today&#039;s stocks to watch: ASML slides, Morgan Stanley beats earnings, and Novocure rises after FDA approval of its lung cancer treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/\" \/>\n<meta property=\"og:site_name\" content=\"OnEquity\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-16T14:17:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/insights.onequity.com\/wp-content\/uploads\/2024\/07\/int-business-mag-en.png\" \/>\n\t<meta property=\"og:image:width\" content=\"850\" \/>\n\t<meta property=\"og:image:height\" content=\"550\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"OnEquity\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"OnEquity\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"\u062f\u0642\u064a\u0642\u062a\u0627\u0646\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\\\/\"},\"author\":{\"name\":\"OnEquity\",\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/#\\\/schema\\\/person\\\/aea7a32034766b228ef53b2fa11b133b\"},\"headline\":\"Today&#8217;s Stocks to Watch: ASML, Morgan Stanley, and Novocure\",\"datePublished\":\"2024-10-16T14:17:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\\\/\"},\"wordCount\":346,\"publisher\":{\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/#organization\"},\"keywords\":[\"Stock Market\",\"Stocks\"],\"articleSection\":[\"Stocks\"],\"inLanguage\":\"ar\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\\\/\",\"url\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\\\/\",\"name\":\"Today's Stocks to Watch: ASML, Morgan Stanley, and Novocure - OnEquity\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/#website\"},\"datePublished\":\"2024-10-16T14:17:31+00:00\",\"description\":\"Today's stocks to watch: ASML slides, Morgan Stanley beats earnings, and Novocure rises after FDA approval of its lung cancer treatment.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Today&#8217;s Stocks to Watch: ASML, Morgan Stanley, and Novocure\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/#website\",\"url\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/\",\"name\":\"OnEquity\",\"description\":\"Your trusted choice in online trading\",\"publisher\":{\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/#organization\",\"name\":\"OnEquity\",\"url\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/insights.onequity.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cropped-onequity-favicon.png\",\"contentUrl\":\"https:\\\/\\\/insights.onequity.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cropped-onequity-favicon.png\",\"width\":512,\"height\":512,\"caption\":\"OnEquity\"},\"image\":{\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/#\\\/schema\\\/person\\\/aea7a32034766b228ef53b2fa11b133b\",\"name\":\"OnEquity\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1c908ff0d0e2f47fe0fea0a6f134fe270d20c6137e577de6d7e74c2f959342f8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1c908ff0d0e2f47fe0fea0a6f134fe270d20c6137e577de6d7e74c2f959342f8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1c908ff0d0e2f47fe0fea0a6f134fe270d20c6137e577de6d7e74c2f959342f8?s=96&d=mm&r=g\",\"caption\":\"OnEquity\"},\"url\":\"https:\\\/\\\/insights.onequity.com\\\/ar\\\/author\\\/antonis\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Today's Stocks to Watch: ASML, Morgan Stanley, and Novocure - OnEquity","description":"Today's stocks to watch: ASML slides, Morgan Stanley beats earnings, and Novocure rises after FDA approval of its lung cancer treatment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/","og_locale":"ar_AR","og_type":"article","og_title":"Today's Stocks to Watch: ASML, Morgan Stanley, and Novocure - OnEquity","og_description":"Today's stocks to watch: ASML slides, Morgan Stanley beats earnings, and Novocure rises after FDA approval of its lung cancer treatment.","og_url":"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/","og_site_name":"OnEquity","article_published_time":"2024-10-16T14:17:31+00:00","og_image":[{"width":850,"height":550,"url":"https:\/\/insights.onequity.com\/wp-content\/uploads\/2024\/07\/int-business-mag-en.png","type":"image\/png"}],"author":"OnEquity","twitter_card":"summary_large_image","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"OnEquity","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"\u062f\u0642\u064a\u0642\u062a\u0627\u0646"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/#article","isPartOf":{"@id":"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/"},"author":{"name":"OnEquity","@id":"https:\/\/insights.onequity.com\/ar\/#\/schema\/person\/aea7a32034766b228ef53b2fa11b133b"},"headline":"Today&#8217;s Stocks to Watch: ASML, Morgan Stanley, and Novocure","datePublished":"2024-10-16T14:17:31+00:00","mainEntityOfPage":{"@id":"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/"},"wordCount":346,"publisher":{"@id":"https:\/\/insights.onequity.com\/ar\/#organization"},"keywords":["Stock Market","Stocks"],"articleSection":["Stocks"],"inLanguage":"ar"},{"@type":"WebPage","@id":"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/","url":"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/","name":"Today's Stocks to Watch: ASML, Morgan Stanley, and Novocure - OnEquity","isPartOf":{"@id":"https:\/\/insights.onequity.com\/ar\/#website"},"datePublished":"2024-10-16T14:17:31+00:00","description":"Today's stocks to watch: ASML slides, Morgan Stanley beats earnings, and Novocure rises after FDA approval of its lung cancer treatment.","breadcrumb":{"@id":"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/insights.onequity.com\/ar\/todays-stocks-to-watch-asml-morgan-stanley-and-novocure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/insights.onequity.com\/ar\/"},{"@type":"ListItem","position":2,"name":"Today&#8217;s Stocks to Watch: ASML, Morgan Stanley, and Novocure"}]},{"@type":"WebSite","@id":"https:\/\/insights.onequity.com\/ar\/#website","url":"https:\/\/insights.onequity.com\/ar\/","name":"OnEquity","description":"Your trusted choice in online trading","publisher":{"@id":"https:\/\/insights.onequity.com\/ar\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/insights.onequity.com\/ar\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/insights.onequity.com\/ar\/#organization","name":"OnEquity","url":"https:\/\/insights.onequity.com\/ar\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/insights.onequity.com\/ar\/#\/schema\/logo\/image\/","url":"https:\/\/insights.onequity.com\/wp-content\/uploads\/2026\/01\/cropped-onequity-favicon.png","contentUrl":"https:\/\/insights.onequity.com\/wp-content\/uploads\/2026\/01\/cropped-onequity-favicon.png","width":512,"height":512,"caption":"OnEquity"},"image":{"@id":"https:\/\/insights.onequity.com\/ar\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/insights.onequity.com\/ar\/#\/schema\/person\/aea7a32034766b228ef53b2fa11b133b","name":"OnEquity","image":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/secure.gravatar.com\/avatar\/1c908ff0d0e2f47fe0fea0a6f134fe270d20c6137e577de6d7e74c2f959342f8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1c908ff0d0e2f47fe0fea0a6f134fe270d20c6137e577de6d7e74c2f959342f8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1c908ff0d0e2f47fe0fea0a6f134fe270d20c6137e577de6d7e74c2f959342f8?s=96&d=mm&r=g","caption":"OnEquity"},"url":"https:\/\/insights.onequity.com\/ar\/author\/antonis\/"}]}},"_links":{"self":[{"href":"https:\/\/insights.onequity.com\/ar\/wp-json\/wp\/v2\/posts\/65145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/insights.onequity.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/insights.onequity.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/insights.onequity.com\/ar\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/insights.onequity.com\/ar\/wp-json\/wp\/v2\/comments?post=65145"}],"version-history":[{"count":0,"href":"https:\/\/insights.onequity.com\/ar\/wp-json\/wp\/v2\/posts\/65145\/revisions"}],"wp:attachment":[{"href":"https:\/\/insights.onequity.com\/ar\/wp-json\/wp\/v2\/media?parent=65145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/insights.onequity.com\/ar\/wp-json\/wp\/v2\/categories?post=65145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/insights.onequity.com\/ar\/wp-json\/wp\/v2\/tags?post=65145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}